AEGIRBIO AB ADVANCES FURTHER WITH “ACCESSIBILITY” MILESTONE COMPLETION IN RADx® TECH PROGRAM
Pioneering Accessibility Project for Multiplex Testing Reaches Key Development MilestoneAegirBio AB is thrilled to announce the successful completion of a pivotal milestone within the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program. Building on the award, AegirBio continues to drive innovation with its digital multiplex self-test platform, specifically designed to improve accessibility for individuals with visual, hearing, and dexterity impairments. The RADx® Tech program, dedicated to expediting diagnostic technology, granted AegirBio an award